Company Filing History:
1 out of 662 
1 out of 10 
1 out of 832,912 Years Active: 2004-2006
Title: Nathan Alderson: Innovator in Diabetic Neuropathy Treatment
Introduction
Nathan Alderson is a notable inventor based in West Columbia, South Carolina. He has made significant contributions to the field of medical treatments, particularly focusing on diabetic neuropathy and its complications. With a total of two patents to his name, Alderson's work is paving the way for innovative solutions in diabetes care.
Latest Patents
Alderson's latest patents include groundbreaking methods for treating diabetic neuropathy. One patent discloses a method that involves administering pyridoxamine or a salt thereof to treat this condition. Another patent provides compositions and methods for modeling post-Amadori AGE formation, identifying effective inhibitors of this process. This invention also teaches methods to treat or prevent diabetes-associated hyperlipidemia, cellular redox imbalances, hypercholesterolemia, hypertriglyceridemia, and atherosclerosis, by administering the compounds to mammals in need.
Career Highlights
Throughout his career, Nathan Alderson has worked with esteemed institutions such as the University of South Carolina and the Kansas University Medical Center. His research and innovations have contributed significantly to the understanding and treatment of diabetes-related complications.
Collaborations
Alderson has collaborated with notable colleagues, including John W. Baynes and Suzanne R. Thorpe. Their combined expertise has further advanced the research in diabetic treatments.
Conclusion
Nathan Alderson's contributions to the field of diabetic neuropathy treatment highlight his innovative spirit and dedication to improving patient care. His patents represent a significant step forward in addressing the challenges faced by individuals with diabetes.